The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block

Clinical and Experimental Immunology

Volumn 104, Issue 3, 1996, Pages 388-393

  Li, J M ^a   Fan, W S ^a   Horsfall, A C ^a   Anderson, A C ^b   Rigby, S ^a   Larsson, E ^b   Venables, P J W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmune diseases; Maternal autoantibodies; Pregnancy

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; CONGENITAL HEART BLOCK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS HEART; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RETROVIRUS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, VIRAL; CONNECTIVE TISSUE DISEASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL HEART; FETUS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HEART BLOCK; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IN SITU HYBRIDIZATION; KIDNEY; LIVER; LUNG; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; SJOGREN'S SYNDROME; SKIN; SPLEEN; VIRAL PROTEINS;

EID: 0030012614     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972; 4:75-101.
2. Ross BA. Congenital complete atrioventricular block. Pediatr Clin North Am 1990; 37:69-78.
3. Taylor PV, Scott JS, Gerlio LM, Esscher E, Scott O. Maternal antibodies against fetal cardiac antigens in congenital heart block. N Engl J Med 1986; 315:667-72.
4. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol 1988; 27:128-32.
5. Ho SY, Esscher E, Anderson RH, Michaelsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 1986; 58:291-4.
6. Gross KR, Petty RE, Linn VL, Allen RC. Maternal autoantibodies and fetal disease. Clin Exp Rheumatol 1989; 7:651-7.
7. Lee LA, Coulter S, Erner S, Chu H. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies. Am J Med 1987; 83:793-6.
8. Horsfall AC, Venables PJW, Taylor PV, Maini RN. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991; 4:165-76.
9. Horsfall AC, Rose LM. Cross-reactive maternal autoantibodies and congenital heart block. J Autoimmune 1992; 5:479-93.
10. Li JM, Horsfall AC, Maini RN. Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin - a role in the pathogenesis of congenital heart block? Clin Exp Immunol 1995; 99:316-24.
11. Ramsey-Goldman R, Hom D, Deng JS et al. Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986;29:1269-73.
12. O'Connell C, O'Brien S, Nash WG, Cohen M. ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology 1984; 138:225-35.
13. Perl A, Banki K. Human endogenous retroviral elements and autoimmunity: data and concepts. Trends Microbiol 1993; 1:153-6.
14. Kato N, Pfeifer-Ohlsson S, Kato M, Larsson E, Rydnert J, Ohlsso R. Cohen M. Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol 1987; 61:2182-91.
15. Cohen M, Powers M, O'Connell C, Kato N. The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology 1985; 147:449-58.
16. Venables PJW, Brookes S, Griffiths D, Weiss RA, Boyd MT. Abundance of endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 1995; 211:589-92.
17. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988; 67:31-40.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
19. Holmgren L, Flam F, Larsson E, Ohlsson R. Successive activation of the platelet-derived growth factor beta receptor and platelet-derived growth factor B genes correlates with the genesis of human choriocarcinoma. Cancer Res 1993; 53:2927-31.
20. Larsson E, Kato N, Cohen M. Human endogenous proviruses. Curr Top Microbiol Immunol 1989 148:115-32.
21. Medstrand P, Lindeskog M, Blomberg J. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol 1992; 73:2463-6.
22. Takeuchi K, Katsumata K, Ikeda H, Minami M, Wakisaka A, Yoshiki T. Expression of endogenous retroviruses. ERV3 and lambda 4-1, in synovial tissues from patients with rheumatoid arthritis. Clin Exp Immunol 1995; 99:338-44.
23. Boyd MT, Bax, CM, Bax BE, Bloxam DL, Weiss RA. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology 1993; 196:905-9.
24. Kato N, Larsson E, Cohen M. Absence of expression of a human endogenous retrovirus is correlated with choriocarcionoma. Int J Cancer 1988; 41:380-5.
25. Rucheton M, Graafland H, Fanton H, Ursule L, Ferrier P, Larsen CJ. Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders. Virology 1985; 144:468-80.
26. Krieg AM, Steinberg AD. Retroviruses and autoimmunity. J Autoimmun 1990; 3:137-66.
27. Schulz TF, Jameson BA, Lopalco L, Siccardi AG, Weiss RA, Moore JP. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? AIDS Res Hum Retroviruses 1992; 8:1571-80